Insider Trading Activity Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) – SVP Sold 89 shares of Stock

Insider Trading Activity For Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT)

Story continues below

Richard J Kim , SVP of Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) reportedly Sold 89 shares of the company’s stock at an average price of 128.64 for a total transaction amount of $11,448.96 SEC Form

Insider Trading History For Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT)

  • On 10/16/2012 Jonathan Silverstein, Director, bought 333,334 with an average share price of $15.00 per share and the total transaction amounting to $5,000,010.00.View SEC Filing
  • On 4/9/2013 David Shapiro, CMO, sold 3,750 with an average share price of $34.41 per share and the total transaction amounting to $129,037.50.View SEC Filing
  • On 5/16/2013 David Shapiro, CMO, sold 5,016 with an average share price of $31.31 per share and the total transaction amounting to $157,050.96.View SEC Filing
  • On 5/20/2013 Barbara Gayle Duncan, CFO, sold 28,200 with an average share price of $34.50 per share and the total transaction amounting to $972,900.00.View SEC Filing
  • On 5/28/2013 Barbara Gayle Duncan, CFO, sold 6,225 with an average share price of $34.50 per share and the total transaction amounting to $214,762.50.View SEC Filing
  • On 6/17/2013 David Shapiro, CMO, sold 5,016 with an average share price of $32.72 per share and the total transaction amounting to $164,123.52.View SEC Filing
  • On 6/19/2013 Barbara Gayle Duncan, CFO, sold 50,575 with an average share price of $34.50 per share and the total transaction amounting to $1,744,837.50.View SEC Filing
  • Analyst Ratings For Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT)
    These are 2 Sell Ratings, 4 Hold Ratings, 10 Buy Ratings .
    The current consensus rating for Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) is Buy (Score: 2.50) with a consensus target price of $203.00 , a potential (63.05% upside)

    Analyst Ratings History For Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT)

    • On 7/24/2015 Royal Bank Of Canada Reiterated Rating Outperform with a price target of $490.00
    • On 8/7/2015 Janney Montgomery Scott Reiterated Rating Buy
    • On 1/28/2016 S&P Equity Research Reiterated Rating Average with a price target of $100.60 to $111.91
    • On 4/9/2016 Bank of America Corporation Reiterated Rating Sell with a price target of $144.00
    • On 5/31/2016 Goldman Sachs Group, Inc. (The) Boost Price Target of rating Neutral with a price target of $114.00 to $128.00
    • On 6/1/2016 Barclays PLC Reiterated Rating Buy with a price target of $200.00 to $205.00
    • On 8/5/2016 Morgan Stanley Reiterated Rating Sell with a price target of $80.00

    Recent Trading Activity for Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT)
    Shares of Intercept Pharmaceuticals, Inc. closed the previous trading session at 124.50 down -0.50 -0.40% with 359,270 shares trading hands.

    An ad to help with our costs